How does Trikatu enhance bioavailability of other herbs?

Trikatu enhances bioavailability primarily through piperine, a compound found in black pepper and long pepper. Piperine inhibits cytochrome P450 enzymes (particularly CYP3A4 and CYP2D6) and P-glycoprotein efflux pumps in the intestinal lining, allowing more of a substance to enter systemic circulation. It also stimulates digestive enzymes and increases intestinal permeability. This mechanism explains why Trikatu is traditionally used as a bioavailability enhancer in Ayurvedic formulations. Evidence level: C (preclinical and traditional data).

Does Trikatu interact with prescription medications?

Yes, Trikatu can interact with medications due to piperine's inhibition of cytochrome P450 enzymes and drug transporters. This may increase blood levels of drugs metabolized by CYP3A4 and CYP2D6, including certain anticoagulants, antihypertensives, and immunosuppressants. Trikatu may potentiate both therapeutic effects and side effects of concurrent medications. Patients taking blood thinners, diabetes medications, or drugs with narrow therapeutic windows should avoid Trikatu without medical supervision. Evidence level: C.

What is the recommended Trikatu dosage for adults?

The traditional Ayurvedic dosage for Trikatu is 1-3 grams of powder taken before meals with warm water, typically 2-3 times daily. For standardized extracts, follow manufacturer guidelines as concentrations vary. Start with lower doses (500mg-1g) to assess tolerance, as the pungent spices can cause gastrointestinal irritation in sensitive individuals. Those with strong digestion may tolerate higher doses. Consult a qualified practitioner for personalized dosing. Evidence level: Traditional.

Is Trikatu safe during pregnancy and breastfeeding?

Trikatu is contraindicated during pregnancy. The formula contains piperine and other compounds that may stimulate uterine contractions or affect fetal development. Long pepper (Piper longum) has traditional abortifacient properties at higher doses. The heating qualities may also aggravate pitta conditions common in pregnancy. Breastfeeding women should also exercise caution due to insufficient safety data. Pregnant and nursing women should avoid Trikatu and consult a healthcare provider for pregnancy-safe alternatives. Evidence level: Traditional/Preclinical.

What are the side effects of Trikatu?

Common side effects of Trikatu include gastrointestinal irritation, heartburn, and acid reflux due to its pungent, heating nature. Some individuals may experience photosensitivity with prolonged use. Trikatu can aggravate peptic ulcers, inflammatory conditions, and hyperacidity. People with gastritis or acid-related disorders should use caution. Discontinue use if experiencing persistent burning sensations, nausea, or skin reactions. Evidence level: Traditional/C.

Trikatu (Zingiber officinale/Piper longum/Piper nigrum)

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Trikatu is a traditional Ayurvedic formulation consisting of Zingiber officinale, Piper nigrum, and Piper longum, used for various ailments including respiratory and digestive disorders [PMID:32964485, PMID:24690772].

Background

Trikatu is a well-known 'Rasayana' in Indian Ayurveda, typically composed of a 1:1:1 ratio of dried fruits of Piper nigrum, Piper longum, and dried rhizomes of Zingiber officinale [PMID:24690772, PMID:15120451].

Traditional uses

It has been prescribed for cough, cold, fever, asthma, respiratory problems, and the improvement of digestive disorders [PMID:24690772]. It is also used to relieve pruritis, pain, and inflammation [PMID:24559814].

Active compounds

The major bioactive alkaloid identified in Trikatu is piperine [PMID:32964485, PMID:30318249]. Other identified components include 6-gingerol [PMID:24690772] and essential oil constituents such as β-Caryophyllene, α-Pinene, linalool, D-Limonene, and Eucalyptol [PMID:40786247].

Mechanism of action

Trikatu may enhance the bioavailability of other drugs by promoting rapid gastrointestinal absorption or protecting drugs from first-pass liver metabolism [PMID:7311598]. In rheumatoid arthritis models, it suppresses pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, MCP-1) and downregulates the NF-κB signaling pathway [PMID:27613480]. Essential oil components may interact with GABAA, CB2, 5-HT1A, 5-HT, and 5-HT2A receptors [PMID:40786247].

Clinical evidence

Evidence BMosquito bite reactions

No significant differences were found between topical Trikatu and a reference product in reducing papule size, pruritis, redness, or pain [PMID:24559814].

Evidence DAlcoholic Liver Disease (Animal Model)

Doses of 200 mg/kg and 400 mg/kg demonstrated significant hepatoprotective effects by improving body weight, total bilirubin, and SGOT [PMID:36466417].

Evidence DRheumatoid Arthritis (Animal Model)

Oral administration (1000 mg/kg) suppressed inflammatory immune responses and pro-inflammatory cytokines [PMID:27613480, PMID:25546349, PMID:24394943].

Evidence DHyperlipidaemia (Animal Model)

Reduced triglycerides and LDL cholesterol while increasing HDL cholesterol, potentially reducing atherosclerosis risk [PMID:15742354].

Evidence DAcute Gouty Arthritis (Animal Model)

Administration of 1000 mg/kg reverted biochemical changes (lysosomal enzymes, lipid peroxidation) to near normal levels [PMID:23674350].

Evidence D

Safety & adverse effects

In acute toxicity studies in rats, a single oral dose of 2,000 mg/kg was well tolerated with no significant changes in mortality, morbidity, or vital organ weight [PMID:19182439]. Sub-acute administration (up to 300 mg/kg daily for 28 days) showed non-significant changes in most parameters [PMID:19182439].

Drug interactions

Trikatu can alter the pharmacokinetics of various drugs: it significantly decreased serum levels of diclofenac sodium [PMID:15120451], decreased the peak plasma concentration (Cmax) of rifampicin [PMID:10363842], and decreased the Tmax of carbamazepine [PMID:27093753]. Conversely, it increased the bioavailability of vasicine and sparteine [PMID:7311598] and increased the plasma concentrations of pefloxacin during the elimination phase in goats [PMID:18296885].

Evidence summary

The majority of evidence is derived from animal models (D) and case reports (D), with one RCT (B) showing no significant effect on mosquito bites. There is strong preclinical evidence for anti-inflammatory and bio-enhancing properties, but limited high-level human clinical data.

PubMed sources

1.PMID: 34081846 (2022) — Is Trikatu an ayurvedic formulation effective for the management of flu-like illness? A narrative review. · Journal of complementary & integrative medicine
2.PMID: 32964485 (2020) — Spice-infused palmyra palm syrup improved cell-mediated immunity in Wistar Albino rats. · Journal of food biochemistry
3.PMID: 36466417 (2022) — Deciphering the impact and mechanism of Trikatu, a spices-based formulation on alcoholic liver disease employing network pharmacology analysis and in vivo validation. · Frontiers in nutrition
4.PMID: 24559814 (2014) — Efficacy and safety of topical Trikatu preparation in, relieving mosquito bite reactions: a randomized controlled trial. · Complementary therapies in medicine
5.PMID: 30318249

Trikatu

Sources & Citations